vTv Therapeutics (VTVT)
(Delayed Data from NSDQ)
$22.38 USD
+1.03 (4.83%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $22.97 +0.59 (2.64%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, vTv Therapeutics Inc. has a market cap of $68.20M, which represents its share price of $21.35 multiplied by its outstanding shares number of 3.19M. As a small-cap company, VTVT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
VTVT 22.38 +1.03(4.83%)
Will VTVT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VTVT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VTVT
The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics
Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More
VTVT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for VTVT
VTVT forms Pocket Pivot on September 19
VTVT's price rises by 1.52% on September 19, though its technical setup remains stable.
Is VTVT building bullish momentum? Slingshot Bullish shows up after sliding 0.69%
vTv Therapeutics trading resumes
vTv Therapeutics trading resumes